American gastroenterological association technical review on the management of Barrett's esophagus

Gastroenterology

Volumn 140, Issue 3, 2011, Pages

  Spechler, Stuart J ^a   Sharma, Prateek ^b   Souza, Rhonda F ^a   Inadomi, John M ^c   Shaheen, Nicholas J ^d  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 METHYLACYL COENZYME A RACEMASE; ACETIC ACID; ACETYLSALICYLIC ACID; BETA CATENIN; BIOLOGICAL MARKER; CELECOXIB; CYCLIN D1; GASTRIN; INDIGO CARMINE; LUGOL; MESSENGER RNA; METHYLENE BLUE; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; PROTEIN P16; PROTEIN P53; PROTON PUMP INHIBITOR; ROFECOXIB; TRANSCRIPTION FACTOR RUNX3;

AGE DISTRIBUTION; AMERICAN GASTROENTEROLOGICAL ASSOCIATION INSTITUTE; ANEUPLOIDY; ANGIOGENESIS; ANTIREFLUX OPERATION; AUTOFLUORESCENCE IMAGING; BARRETT ESOPHAGUS; BODY FAT DISTRIBUTION; BODY MASS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL JUNCTION; CELL PROLIFERATION; CELL STRUCTURE; CELL TYPE; CHEMOPROPHYLAXIS; CHROMOENDOSCOPY; CHROMOSOME 17P; CLINICAL PRACTICE; COLUMNAR EPITHELIUM; CONFOCAL LASER MICROSCOPY; CONTINUING EDUCATION; DIFFUSE REFLECTANCE SPECTROSCOPY; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSPLASIA; ENDOSCOPIC MUCOSAL RESECTION; ENDOSCOPIC THERAPY; EPITHELIUM; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOSCOPY; ESOPHAGUS RESECTION; ETHNICITY; EVIDENCE BASED MEDICINE; FOLLOW UP; GASTRIN BLOOD LEVEL; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL TOXICITY; GENE ACTIVATION; GENE EXPRESSION; GENE SILENCING; GENOMIC INSTABILITY; HEALTH CARE COST; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH STATUS; HIGH FIBER DIET; HIGH RISK POPULATION; HISTOCHEMISTRY; HUMAN; IMMUNOHISTOCHEMISTRY; INTESTINE EPITHELIUM CELL; INTESTINE METAPLASIA; LIFE EXPECTANCY; LIGHT SCATTERING; LOW DRUG DOSE; LOWER ESOPHAGUS SPHINCTER; MEDICAL LITERATURE; MEDICAL SOCIETY; NONHUMAN; OBESITY; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT CARE; PATIENT SELECTION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; PROTEIN METHYLATION; QUALITY OF LIFE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; STOMACH FUNDUS; SURVIVAL RATE; SURVIVAL TIME; TETRAPLOIDY; TREATMENT OUTCOME;

EID: 79952305740     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2011.01.031     Document Type: Review

References (318)

1. P. Sharma, K. McQuaid, J. Dent AGA Chicago Workshop A critical review of the diagnosis and management of Barrett's esophagus: the AGA Chicago Workshop Gastroenterology 127 2004 310 330 (Pubitemid 38962298)
2. N. Vakil, S.V. van Zanten, P. Kahrilas Global Consensus Group The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus Am J Gastroenterol 101 2006 1900 1920
3. K.K. Wang, R.E. Sampliner Practice Parameters Committee of the American College of Gastroenterology Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 2008 788 797 (Pubitemid 351406009)
4. N.J. Shaheen, and J.E. Richter Barrett's oesophagus Lancet 373 2009 850 861
5. S.A. McClave, H.W. Boyce Jr, and M.R. Gottfried Early diagnosis of columnar-lined esophagus: a new endoscopic criterion Gastrointest Endosc 33 1987 413 416 (Pubitemid 18018923)
6. W. Choi do, S.N. Oh, and S.J. Baek Endoscopically observed lower esophageal capillary patterns Korean J Intern Med 17 2002 245 248
7. A. Vianna, P.C. Hayes, and G. Moscoso Normal venous circulation of the gastroesophageal junction A route to understanding varices Gastroenterology 93 1987 876 889 (Pubitemid 17156016)
8. A. Paull, J.S. Trier, and M.D. Dalton The histologic spectrum of Barrett's esophagus N Engl J Med 295 1976 476 480
9. J. Hayward The lower end of the oesophagus Thorax 16 1961 36 41
10. S.J. Spechler Intestinal metaplasia at the gastroesophageal junction Gastroenterology 126 2004 567 575 (Pubitemid 38182313)
11. P. Chandrasoma Pathophysiology of Barrett's esophagus Semin Thorac Cardiovasc Surg 9 1997 270 278
12. W. Liu, H. Hahn, and R.D. Odze Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell-containing epithelium Am J Gastroenterol 104 2009 816 824
13. H.P. Hahn, P.L. Blount, and K. Ayub Intestinal differentiation in metaplastic, nongoblet columnar epithelium in the esophagus Am J Surg Pathol 33 2009 1006 1015
14. K. Takubo, J. Aida, and Y. Naomoto Cardiac rather than intestinal-type background in endoscopic resection specimens of minute Barrett adenocarcinoma Hum Pathol 40 2009 65 74
15. N.J. Shaheen, M.A. Crosby, and E.M. Bozymski Is there publication bias in the reporting of cancer risk in Barrett's esophagus? Gastroenterology 119 2000 333 338 (Pubitemid 30621983)
16. P. Sharma, T.G. Morales, and R.E. Sampliner Short segment Barrett's esophagus The need for standardization of the definition and of endoscopic criteria Am J Gastroenterol 93 1998 1033 1036 (Pubitemid 29080945)
17. P. Sharma, J. Dent, and D. Armstrong The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria Gastroenterology 131 2006 1392 1399 (Pubitemid 44708937)
18. C.S. Robertson, J.F. Mayberry, and D.A. Nicholson Value of endoscopic surveillance in the detection of neoplastic change in Barrett's oesophagus Br J Surg 75 1988 760 763
19. B.J. Reid, P.L. Blount, and C.E. Rubin Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort Gastroenterology 102 1992 1212 1219
20. J.F. Bartlesman, W. Hameeteman, and G.N. Tytgat Barrett's oesophagus Eur J Cancer Prev 1 1992 323 325
21. D.M. Aldulaimi, M. Cox, and C.U. Nwokolo Barrett's surveillance is worthwhile and detects curable cancers A prospective cohort study addressing cancer incidence, treatment outcome and survival Eur J Gastroenterol Hepatol 17 2005 943 950 (Pubitemid 41192133)
22. E.Y. Chang, C.D. Morris, and A.K. Seltman The effect of antireflux surgery on esophageal carcinogenesis in patients with Barrett esophagus: a systematic review Ann Surg 246 2007 11 21 (Pubitemid 47012200)
23. T. Thomas, K.R. Abrams, and J.S. De Caestecker Meta analysis: cancer risk in Barrett's oesophagus Aliment Pharmacol Ther 26 2007 1465 1477 (Pubitemid 350178802)
24. F. Yousef, C. Cardwell, and M.M. Cantwell The incidence of esophageal cancer and high-grade dysplasia in Barrett's esophagus: a systematic review and meta-analysis Am J Epidemiol 168 2008 237 249 (Pubitemid 352019777)
25. M.B. Cook, C.P. Wild, and S.M. Everett Risk of mortality and cancer incidence in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 16 2007 2090 2096 (Pubitemid 47621185)
26. B.T. Cooper, W. Chapman, and C.S. Neumann Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence Aliment Pharmacol Ther 23 2006 727 733 (Pubitemid 43344591)
27. P.A. Gatenby, J.R. Ramus, and C.P. Caygill Treatment modality and risk of development of dysplasia and adenocarcinoma in columnar-lined esophagus Dis Esophagus 22 2009 133 142
28. J. Alcedo, A. Ferrandez, and J. Arenas Trends in Barrett's esophagus diagnosis in Southern Europe: implications for surveillance Dis Esophagus 22 2009 239 248
29. L.A. Anderson, L.J. Murray, and S.J. Murphy Mortality in Barrett's oesophagus: results from a population based study Gut 52 2003 1081 1084 (Pubitemid 36877416)
30. V.F. Eckardt, G. Kanzler, and G. Bernhard Life expectancy and cancer risk in patients with Barrett's esophagus: a prospective controlled investigation Am J Med 111 2001 33 37 (Pubitemid 32635259)
31. P. Moayyedi, N. Burch, and N. Akhtar-Danesh Mortality rates in patients with Barrett's oesophagus Aliment Pharmacol Ther 27 2008 316 320
32. M. Solaymani-Dodaran, R.F. Logan, and J. West Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study Am J Gastroenterol 100 2005 2616 2621
33. P.S. Rana, and D.A. Johnston Incidence of adenocarcinoma and mortality in patients with Barrett's oesophagus diagnosed between 1976 and 1986: implications for endoscopic surveillance Dis Esophagus 13 2000 28 31
34. A. Van der Burgh, J. Dees, and W.C. Hop Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus Gut 39 1996 5 8 (Pubitemid 26239094)
35. S.T. Mayne, H.A. Risch, and R. Dubrow Nutrient intake and risk of subtypes of esophageal and gastric cancer Cancer Epidemiol Biomarkers Prev 10 2001 1055 1062 (Pubitemid 32959152)
36. S.D. Crockett, Q.K. Lippmann, and E.S. Dellon Health-related quality of life in patients with Barrett's esophagus: a systematic review Clin Gastroenterol Hepatol 7 2009 613 623
37. J.E. Ware Jr, and C.D. Sherbourne The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med Care 30 1992 473 483
38. I.K. Wiklund, O. Junghard, and E. Grace Quality of Life in Reflux and Dyspepsia patients Psychometric documentation of a new disease-specific questionnaire (QOLRAD) Eur J Surg Suppl 583 1998 41 49 (Pubitemid 29054907)
39. E. Eypasch, J.I. Williams, and S. Wood-Dauphinee Gastrointestinal Quality of Life Index: development, validation and application of a new instrument Br J Surg 82 1995 216 222
40. L.B. Gerson, N. Ullah, and T. Hastie Does cancer risk affect health-related quality of life in patients with Barrett's esophagus? Gastrointest Endosc 65 2007 16 25 (Pubitemid 44932161)
41. N.J. Shaheen, B. Green, and R.K. Medapalli The perception of cancer risk in patients with prevalent Barrett's esophagus enrolled in an endoscopic surveillance program Gastroenterology 129 2005 429 436 (Pubitemid 41096631)
42. N.J. Shaheen, G.S. Dulai, and B. Ascher Effect of a new diagnosis of Barrett's esophagus on insurance status Am J Gastroenterol 100 2005 577 580 (Pubitemid 40487555)
43. J.A. Abrams, S. Fields, and C.J. Lightdale Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy Clin Gastroenterol Hepatol 6 2008 30 34 (Pubitemid 50008419)
44. Z.R. Edelstein, M.P. Bronner, and S.N. Rosen Risk factors for Barrett's esophagus among patients with gastroesophageal reflux disease: a community clinic-based case-control study Am J Gastroenterol 104 2009 834 842
45. B.T. Cooper, W. Chapman, and C.S. Neumann Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence Aliment Pharmacol Ther 23 2006 727 733 (Pubitemid 43344591)
46. G.M. Campos, S.R. DeMeester, and J.H. Peters Predictive factors of Barrett esophagus: multivariate analysis of 502 patients with gastroesophageal reflux disease Arch Surg 136 2001 1267 1273 (Pubitemid 33043514)
47. G.W. Falk, P.N. Thota, and J.E. Richter Barrett's esophagus in women: demographic features and progression to high-grade dysplasia and cancer Clin Gastroenterol Hepatol 3 2005 1089 1094 (Pubitemid 41565374)
48. D.A. Corley, A. Kubo, and T.R. Levin Race, ethnicity, sex and temporal differences in Barrett's oesophagus diagnosis: a large community-based study, 19942006 Gut 58 2009 182 188
49. M.B. Cook, C.P. Wild, and D. Forman A systematic review and meta-analysis of the sex ratio for Barrett's esophagus, erosive reflux disease, and nonerosive reflux disease Am J Epidemiol 162 2005 1050 1061 (Pubitemid 41746617)
50. D.K. Rex, O.W. Cummings, and M. Shaw Screening for Barrett's esophagus in colonoscopy patients with and without heartburn Gastroenterology 125 2003 1670 1677 (Pubitemid 37500431)
51. M.A. Eloubeidi, and D. Provenzale Clinical and demographic predictors of Barrett's esophagus among patients with gastroesophageal reflux disease: a multivariable analysis in veterans J Clin Gastroenterol 33 2001 306 309 (Pubitemid 32880970)
52. R. Srinivasan, R. Tutuian, and P. Schoenfeld Profile of GERD in the adult population of a northeast urban community J Clin Gastroenterol 38 2004 651 657 (Pubitemid 39096793)
53. S.J. Spechler, S.K. Jain, and D.A. Tendler Racial differences in the frequency of symptoms and complications of gastro-oesophageal reflux disease Aliment Pharmacol Ther 16 2002 1795 1800
54. G.M. Eisen, R.S. Sandler, and S. Murray The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus [see comments] Am J Gastroenterol 92 1997 27 31 (Pubitemid 27027023)
55. B. Avidan, A. Sonnenberg, and T.G. Schnell Hiatal hernia and acid reflux frequency predict presence and length of Barrett's esophagus Dig Dis Sci 47 2002 256 264 (Pubitemid 34123982)
56. K.J. Smith, S.M. O'Brien, and B.M. Smithers Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus Cancer Epidemiol Biomarkers Prev 14 2005 2481 2486 (Pubitemid 41752705)
57. D.A. Lieberman, M. Oehlke, and M. Helfand Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy Am J Gastroenterol 92 1997 1293 1297
58. L. Monaco, A. Brillantino, and F. Torelli Prevalence of bile reflux in gastroesophageal reflux disease patients not responsive to proton pump inhibitors World J Gastroenterol 15 2009 334 338
59. Z.R. Edelstein, D.C. Farrow, and M.P. Bronner Central adiposity and risk of Barrett's esophagus Gastroenterology 133 2007 403 411 (Pubitemid 47187351)
60. H.B. El Serag, P. Kvapil, and J. Hacken-Bitar Abdominal obesity and the risk of Barrett's esophagus Am J Gastroenterol 100 2005 2151 2156
61. P. Kamat, S. Wen, and J. Morris Exploring the association between elevated body mass index and Barrett's esophagus: a systematic review and meta-analysis Ann Thorac Surg 87 2009 655 662
62. D.A. Corley, A. Kubo, and T.R. Levin Abdominal obesity and body mass index as risk factors for Barrett's esophagus Gastroenterology 133 2007 34 41 (Pubitemid 47031134)
63. J. Ronkainen, P. Aro, and T. Storskrubb Prevalence of Barrett's esophagus in the general population: an endoscopic study Gastroenterology 129 2005 1825 1831 (Pubitemid 41772961)
64. T. Akiyama, M. Inamori, and H. Iida Alcohol consumption is associated with an increased risk of erosive esophagitis and Barrett's epithelium in Japanese men BMC Gastroenterol 8 2008 58
65. L.A. Anderson, M.M. Cantwell, and R.G. Watson The association between alcohol and reflux esophagitis, Barrett's esophagus, and esophageal adenocarcinoma Gastroenterology 136 2009 799 805
66. A. Kubo, T.R. Levin, and G. Block Alcohol types and sociodemographic characteristics as risk factors for Barrett's esophagus Gastroenterology 136 2009 806 815
67. A. Kubo, T.R. Levin, and G. Block Cigarette smoking and the risk of Barrett's esophagus Cancer Causes Control 20 2009 303 311
68. O.M. Thompson, S.A. Beresford, and E.A. Kirk Vegetable and fruit intakes and risk of Barrett's esophagus in men and women Am J Clin Nutr 89 2009 890 896
69. A. Kubo, T.R. Levin, and G. Block Dietary patterns and the risk of Barrett's esophagus Am J Epidemiol 167 2008 839 846 (Pubitemid 351451748)
70. J.H. Rubenstein, S.D. Saini, and L. Kuhn Influence of malpractice history on the practice of screening and surveillance for Barrett's esophagus Am J Gastroenterol 103 2008 842 849 (Pubitemid 351501086)
71. W.K. Hirota, M.J. Zuckerman, and D.G. Adler ASGE guideline: the role of endoscopy in the surveillance of premalignant conditions of the upper GI tract Gastrointest Endosc 63 2006 570 580
72. K.K. Wang, and R.E. Sampliner Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 2008 788 797 (Pubitemid 351406009)
73. R.J. Playford New British Society of Gastroenterology (BSG) guidelines for the diagnosis and management of Barrett's oesophagus Gut 55 2006 442
74. D.A. Corley, T.R. Levin, and L.A. Habel Surveillance and survival in Barrett's adenocarcinomas: a population-based study Gastroenterology 122 2002 633 640 (Pubitemid 34173814)
75. J.W. Van Sandick, J.J. van Lanschot, and B.W. Kuiken Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma Gut 43 1998 216 222 (Pubitemid 28348324)
76. J.M. Inadomi, R. Sampliner, and J. Lagergren Screening and surveillance for Barrett esophagus in high-risk groups: a cost-utility analysis [comment] Ann Intern Med 138 2003 176 186 (Pubitemid 36231623)
77. D. Provenzale, C. Schmitt, and J.B. Wong Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk Am J Gastroenterol 94 1999 2043 2053 (Pubitemid 29374530)
78. J. Lagergren, R. Bergstrom, and A. Lindgren Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma N Engl J Med 340 1999 825 831 (Pubitemid 29142625)
79. G.R. Locke III, N.J. Talley, and S.L. Fett Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota Gastroenterology 112 1997 1448 1456 (Pubitemid 27181367)
80. H. Pohl, and H.G. Welch The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence J Natl Cancer Inst 97 2005 142 146 (Pubitemid 40277094)
81. T.G. Schnell, S.J. Sontag, and G. Chejfec Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 2001 1607 1619 (Pubitemid 32523480)
82. M.A. Eloubeidi, and D. Provenzale Does this patient have Barrett's esophagus? The utility of predicting Barrett's esophagus at the index endoscopy Am J Gastroenterol 94 1999 937 943 (Pubitemid 29173605)
83. D. Chatelain, and J.F. Flejou High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins Virchows Arch 442 2003 18 24 (Pubitemid 36221344)
84. E. Montgomery, M.P. Bronner, and J.R. Goldblum Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation Hum Pathol 32 2001 368 378 (Pubitemid 32378298)
85. N.J. Shaheen, and D. Provenzale Screening strategies in gastroesophageal reflux disease: early identification of esophageal carcinoma Adv Intern Med 47 2001 137 157 (Pubitemid 33791977)
86. S.J. Spechler Dysplasia in Barrett's esophagus: limitations of current management strategies Am J Gastroenterol 100 2005 927 935 (Pubitemid 40592389)
87. J.M. Collard High-grade dysplasia in Barrett's esophagus The case for esophagectomy Chest Surg Clin North Am 12 2002 77 92
88. V.J. Konda, A.S. Ross, and M.K. Ferguson Is the risk of concomitant invasive esophageal cancer in high-grade dysplasia in Barrett's esophagus overestimated? Clin Gastroenterol Hepatol 6 2008 159 164
89. A. Rastogi, S. Puli, and H.B. El-Serag Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis Gastrointest Endosc 67 2008 394 398 (Pubitemid 351260043)
90. T.G. Schnell, S.J. Sontag, and G. Chejfec Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 2001 1607 1619 (Pubitemid 32523480)
91. B.J. Reid, D.S. Levine, and G. Longton Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets Am J Gastroenterol 95 2000 1669 1676 (Pubitemid 30485000)
92. P. Sharma, G.W. Falk, and A.P. Weston Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus Clin Gastroenterol Hepatol 4 2006 566 572 (Pubitemid 44308164)
93. E. Montgomery, J.R. Goldblum, and J.K. Greenson Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study Hum Pathol 32 2001 379 388 (Pubitemid 32378299)
94. P. Sharma Low-grade dysplasia in Barrett's esophagus Gastroenterology 127 2004 1233 1238 (Pubitemid 39345891)
95. A. Srivastava, J.L. Hornick, and X. Li Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus Am J Gastroenterol 102 2007 483 493 (Pubitemid 46328161)
96. R.C. Fitzgerald, I.T. Saeed, and D. Khoo Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus Dig Dis Sci 46 2001 1892 1898 (Pubitemid 32844155)
97. W.L. Curvers, F.P. Peters, and B. Elzer Quality of Barrett's surveillance in The Netherlands: a standardized review of endoscopy and pathology reports Eur J Gastroenterol Hepatol 20 2008 601 607
98. J.A. Abrams, R.C. Kapel, and G.M. Lindberg Adherence to biopsy guidelines for Barrett's esophagus surveillance in the community setting in the United States Clin Gastroenterol Hepatol 7 2009 736 742
99. J.M. Streitz Jr, C.W. Andrews Jr, and F.H. Ellis Jr Endoscopic surveillance of Barrett's esophagus Does it help? J Thorac Cardiovasc Surg 105 1993 383 387
100. J.H. Peters, G.W. Clark, and A.P. Ireland Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients J Thorac Cardiovasc Surg 108 1994 813 821
101. A. Fountoulakis, K.D. Zafirellis, and K. Dolan Effect of surveillance of Barrett's oesophagus on the clinical outcome of oesophageal cancer Br J Surg 91 2004 997 1003 (Pubitemid 39070814)
102. G.S. Cooper, Z. Yuan, and A. Chak Association of prediagnosis endoscopy with stage and survival in adenocarcinoma of the esophagus and gastric cardia Cancer 95 2002 32 38 (Pubitemid 34743479)
103. G.S. Cooper, T.D. Kou, and A. Chak Receipt of previous diagnoses and endoscopy and outcome from esophageal adenocarcinoma: a population-based study with temporal trends Am J Gastroenterol 104 2009 1356 1362
104. D.J. Kearney, C. Crump, and C. Maynard A case-control study of endoscopy and mortality from adenocarcinoma of the esophagus or gastric cardia in persons with GERD Gastrointest Endosc 57 2003 823 829 (Pubitemid 47243609)
105. J.H. Rubenstein, A. Sonnenberg, and J. Davis Effect of a prior endoscopy on outcomes of esophageal adenocarcinoma among United States veterans Gastrointest Endosc 68 2008 849 855
106. B.J. Reid, R.C. Haggitt, and C.E. Rubin Observer variation in the diagnosis of dysplasia in Barrett's esophagus Hum Pathol 19 1988 166 178 (Pubitemid 18091022)
107. E. Downs-Kelly, J.E. Mendelin, and A.E. Bennett Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies Am J Gastroenterol 103 2008 2333 2340
108. R.D. Odze Diagnosis and grading of dysplasia in Barrett's oesophagus J Clin Pathol 59 2006 1029 1038 (Pubitemid 44570324)
109. H. van Dekken, W.C. Hop, and H.W. Tilanus Immunohistochemical evaluation of a panel of tumor cell markers during malignant progression in Barrett esophagus Am J Clin Pathol 130 2008 745 753
110. R. Dorer, and R.D. Odze AMACR immunostaining is useful in detecting dysplastic epithelium in Barrett's esophagus, ulcerative colitis, and Crohn's disease Am J Surg Pathol 30 2006 871 877 (Pubitemid 44264978)
111. X.Y. Shi, B. Bhagwandeen, and A.S. Leong p16, cyclin D1, Ki-67, and AMACR as markers for dysplasia in Barrett esophagus Appl Immunohistochem Mol Morphol 16 2008 447 452
112. E.E. Hennig, M. Mikula, and J. Orlowska Large intra- and inter-individual variability of genes expression levels limits potential predictive value of molecular diagnosis of dysplasia in Barrett's esophagus J Mol Med 86 2008 233 242 (Pubitemid 351172128)
113. B.J. Reid, D.S. Levine, and G. Longton Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets Am J Gastroenterol 95 2000 1669 1676 (Pubitemid 30485000)
114. P.S. Rabinovitch, G. Longton, and P.L. Blount Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables Am J Gastroenterol 96 2001 3071 3083 (Pubitemid 33095344)
115. M. Kerkhof, E.W. Steyerberg, and J.G. Kusters Aneuploidy and high expression of p53 and Ki67 is associated with neoplastic progression in Barrett esophagus Cancer Biomark 4 2008 1 10 (Pubitemid 351343907)
116. Q. Huang, C. Yu, and X. Zhang Comparison of DNA histograms by standard flow cytometry and image cytometry on sections in Barrett's adenocarcinoma BMC Clin Pathol 8 2008 5
117. A.M. Rygiel, F. Milano, and F.J. Ten Kate Assessment of chromosomal gains as compared to DNA content changes is more useful to detect dysplasia in Barrett's esophagus brush cytology specimens Genes Chromosomes Cancer 47 2008 396 404 (Pubitemid 351451794)
118. B.J. Reid, L.J. Prevo, and P.C. Galipeau Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression Am J Gastroenterol 96 2001 2839 2848 (Pubitemid 32959522)
119. P.C. Galipeau, X. Li, and P.L. Blount NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma PLoS Med 4 2007 e67
120. M. Fahmy, M. Skacel, and T.L. Gramlich Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens Mod Pathol 17 2004 588 596 (Pubitemid 38868427)
121. V.J. Wongsurawat, J.C. Finley, and P.C. Galipeau Genetic mechanisms of TP53 loss of heterozygosity in Barrett's esophagus: implications for biomarker validation Cancer Epidemiol Biomarkers Prev 15 2006 509 516
122. R. Cestari, V. Villanacci, and E. Rossi Fluorescence in situ hybridization to evaluate dysplasia in Barrett's esophagus: a pilot study Cancer Lett 251 2007 278 287 (Pubitemid 46669806)
123. A.M. Rygiel, J.W. van Baal, and F. Milano Efficient automated assessment of genetic abnormalities detected by fluorescence in situ hybridization on brush cytology in a Barrett esophagus surveillance population Cancer 109 2007 1980 1988 (Pubitemid 46744191)
124. K. Schulmann, A. Sterian, and A. Berki Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression risk Oncogene 24 2005 4138 4148 (Pubitemid 40897058)
125. Z. Jin, Y. Cheng, and W. Gu A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus Cancer Res 69 2009 4112 4115
126. D.B. Nelson, K.P. Block, and J.J. Bosco High resolution and high-magnification endoscopy: September 2000 Gastrointest Endosc 52 2000 864 866
127. P. Sharma Magnification endoscopy Gastrointest Endosc 61 2005 435 443 (Pubitemid 40349043)
128. K. Yao, Y. Takaki, and J. Ohara Magnification endoscopy outlines the microvascular architecture and extent of Barrett's intramucosal carcinoma prior to endoscopic resection Gastrointest Endosc 63 2006 1064 1065 (Pubitemid 43776168)
129. S. Wani, and P. Sharma Endoscopic surface imaging of Barrett's esophagus: an optimistic view Gastroenterology 133 2007 11 13 (Pubitemid 47031169)
130. M.A. Kara, M.E. Smits, and W.D. Rosmolen A randomized cross-over study comparing light-induced fluorescence endoscopy with standard video endoscopy for the detection of early neoplasia in Barrett's esophagus Gastrointest Endosc 61 2005 671 678 (Pubitemid 40603034)
131. M.A. Kara, F.P. Peters, and W.D. Rosmolen High-resolution endoscopy plus chromoendoscopy or narrow-band imaging in Barrett's esophagus: a prospective randomized crossover study Endoscopy 37 2005 929 936 (Pubitemid 41489261)
132. M.I. Canto, S. Setrakian, and J.E. Willis Methylene blue staining of dysplastic and nondysplastic Barrett's esophagus: an in vivo and ex vivo study Endoscopy 33 2001 391 400 (Pubitemid 32586443)
133. P. Sharma, M. Topalovski, and M.S. Mayo Methylene blue chromoendoscopy for detection of short-segment Barrett's esophagus Gastrointest Endosc 54 2001 289 293 (Pubitemid 33665506)
134. H.P. Breyer, S.G. Silva De Barros, and I. Maguilnik Does methylene blue detect intestinal metaplasia in Barrett's esophagus? Gastrointest Endosc 57 2003 505 509 (Pubitemid 36402716)
135. J.D. Horwhat, C.L. Maydonovitch, and F. Ramos A randomized comparison of methylene blue-directed biopsy versus conventional four-quadrant biopsy for the detection of intestinal metaplasia and dysplasia in patients with long-segment Barrett's esophagus Am J Gastroenterol 103 2008 546 554 (Pubitemid 351405968)
136. C.H. Lim, O. Rotimi, and S.P. Dexter Randomized crossover study that used methylene blue or random 4-quadrant biopsy for the diagnosis of dysplasia in Barrett's esophagus Gastrointest Endosc 64 2006 195 199 (Pubitemid 44081899)
137. A. Meining, T. Rsch, and R. Kiesslich Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction Endoscopy 36 2004 160 164 (Pubitemid 38180602)
138. P. Sharma, A.P. Weston, and M. Topalovski Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus Gut 52 2003 24 27 (Pubitemid 36020759)
139. M. Guelrud, and I. Herrera Acetic acid improves identification of remnant islands of Barrett's epithelium after endoscopic therapy Gastrointest Endosc 47 1998 512 515 (Pubitemid 28287571)
140. S. Ngamruengphong, V.K. Sharma, and A. Das Diagnostic yield of methylene blue chromoendoscopy for detecting specialized intestinal metaplasia and dysplasia in Barrett's esophagus: a meta-analysis Gastrointest Endosc 69 2009 1021 1028
141. M. Guelrud, I. Herrera, and H. Essenfeld Enhanced magnification endoscopy: a new technique to identify specialized intestinal metaplasia in Barrett's esophagus Gastrointest Endosc 53 2001 559 565 (Pubitemid 33587027)
142. J.R. Olliver, C.P. Wild, and P. Sahay Chromoendoscopy with methylene blue and associated DNA damage in Barrett's oesophagus Lancet 362 2003 373 374 (Pubitemid 36945061)
143. K. Gono, T. Obi, and M. Yamaguchi Appearance of enhanced tissue features in narrow-band endoscopic imaging J Biomed Opt 9 2004 568 577
144. J. Pohl, A. May, and T. Rabenstein Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett's esophagus Endoscopy 39 2007 594 598 (Pubitemid 47098995)
145. P. Sharma, A. Bansal, and S. Mathur The utility of a novel narrow band imaging endoscopy system in patients with Barrett's esophagus Gastrointest Endosc 64 2006 167 175 (Pubitemid 44081900)
146. M.A. Kara, M. Ennahachi, and P. Fockens Detection and classification of the mucosal and vascular patterns (mucosal morphology) in Barrett's esophagus by using narrow band imaging Gastrointest Endosc 64 2006 155 166 (Pubitemid 44062482)
147. W. Curvers, L. Baak, and R. Kiesslich Chromoendoscopy and narrow-band imaging compared with high-resolution magnification endoscopy in Barrett's esophagus Gastroenterology 134 2008 670 679 (Pubitemid 351312734)
148. H.C. Wolfsen, J.E. Crook, and M. Krishna Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's esophagus Gastroenterology 135 2008 24 31 (Pubitemid 351899007)
149. P. Sharma, A. Bansal, and R. Hawes Detection of metaplasia and neoplasia in patients with Barrett's esophagus using high-definition white light endoscopy versus narrow band imaging: a prospective, multi-center, randomized, crossover trial Gastrointest Endosc 69 2009 AB135
150. M.A. Kara, F.P. Peters, and F.J.W. ten Kate Endoscopic video autofluorescence imaging may improve the detection of early neoplasia in patients with Barrett's esophagus Gastrointest Endosc 61 2005 679 685 (Pubitemid 40603035)
151. M.A. Kara, F.P. Peters, and P. Fockens Endoscopic video-autofluorescence imaging followed by narrow band imaging for detecting early neoplasia in Barrett's esophagus Gastrointest Endosc 64 2006 176 185 (Pubitemid 44062483)
152. W.L. Curvers, R. Singh, and L.M. Wong Kee Song Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus; a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system Gut 57 2008 167 172 (Pubitemid 351158041)
153. R. Kiesslich, L. Gossner, and M. Goetz In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy Clin Gastroenterol Hepatol 4 2006 979 987 (Pubitemid 44118843)
154. H. Pohl, T. Rosch, and M. Vieth Miniprobe confocal laser microscopy for the detection of invisible neoplasia in patients with Barrett's esophagus Gut 57 2008 1648 1653
155. A. Meining, D. Saur, and M. Bajbouj In vivo histopathology for detection of gastrointestinal neoplasia with a portable, confocal miniprobe: an examiner blinded analysis Clin Gastroenterol Hepatol 5 2007 1261 1267 (Pubitemid 350019048)
156. R. Kiesslich, J. Burg, and M. Vieth Confocal laser endoscopy for diagnosing intraepithelial neoplasias and colorectal cancer in vivo Gastroenterology 127 2004 706 713 (Pubitemid 39208403)
157. A.L. Polglase, W.J. McLaren, and S.A. Skinner A fluorescence confocal endomicroscope for in vivo microscopy of the upper- and the lower-GI tract Gastrointest Endosc 62 2005 686 695 (Pubitemid 41502992)
158. V. Becker, T. Vercauteren, and C.H. von Weyhern High-resolution miniprobe-based confocal microscopy in combination with video mosaicing (with video) Gastrointest Endosc 66 2007 1001 1007 (Pubitemid 47610769)
159. Y. Kumagai, K. Monma, and K. Kawada Magnifying chromoendoscopy of the esophagus: in-vivo pathological diagnosis using an endocytoscopy system Endoscopy 36 2004 590 594 (Pubitemid 38979151)
160. H. Pohl, M. Koch, and A. Khalifa Evaluation of endocytoscopy in the surveillance of patients with Barrett's esophagus Endoscopy 39 2007 492 496 (Pubitemid 46971572)
161. I. Georgakoudi, B. Jacobson, and J. Van Dam Fluorescence, reflectance and light scattering spectroscopy for evaluating dysplasia in patients with Barrett's esophagus Gastroenterology 120 2001 1620 1629 (Pubitemid 32523481)
162. M.A. Ortner, B. Ebert, and E. Hein Time gated fluorescence spectroscopy in Barrett's oesophagus Gut 52 2003 28 33 (Pubitemid 36020760)
163. M.B. Wallace, L.T. Perelman, and V. Backman Endoscopic detection of dysplasia in patients with Barrett's esophagus using light-scattering spectroscopy Gastroenterology 119 2000 677 682
164. K. Kobayashi, J.A. Izatt, and M.D. Kulkarni High-resolution cross-sectional imaging of the gastrointestinal tract using optical coherence tomography: preliminary results Gastrointest Endosc 47 1998 515 523 (Pubitemid 28287572)
165. B.E. Bouma, G.J. Tearney, and C.C. Compton High-resolution imaging of the human esophagus and stomach in vivo using optical coherence tomography Gastrointest Endosc 51 2000 467 474 (Pubitemid 30204772)
166. J.M. Poneros, S. Brand, and B.E. Bouma Diagnosis of specialized metaplasia by optical coherence tomography Gastroenterology 120 2001 7 12 (Pubitemid 32061863)
167. J.A. Evans, J.M. Poneros, and B.E. Bouma Optical coherence tomography to identify intramucosal carcinoma and high-grade dysplasia in Barrett's esophagus Clin Gastroenterol Hepatol 4 2006 38 43 (Pubitemid 43129522)
168. X. Qi, M.V. Sivak, and G. Isenberg Computer-aided diagnosis of dysplasia in Barrett's esophagus using endoscopic optical coherence tomography J Biomed Opt 11 2006 044010
169. G.J. Kelloff, S.M. Lippman, and A.J. Dannenberg Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer-a plan to move forward Clin Cancer Res 12 2006 3661 3697 (Pubitemid 44000248)
170. R.C. Fitzgerald, M.B. Omary, and G. Triadafilopoulos Dynamic effects of acid on Barrett's esophagus An ex vivo proliferation and differentiation model J Clin Invest 98 1996 2120 2128 (Pubitemid 26376301)
171. V.N. Shirvani, R. Ouatu-Lascar, and B.S. Kaur Cyclooxygenase 2 expression in Barrett's Esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure Gastroenterology 118 2000 487 496 (Pubitemid 30140846)
172. R.F. Souza, K. Shewmake, and L.S. Terada Acid exposure activates the mitogen-activated protein kinase pathways in Barrett's esophagus Gastroenterology 122 2002 299 307 (Pubitemid 34126346)
173. N.J. Clemons, K.E. McColl, and R.C. Fitzgerald Nitric oxide and acid induce double-strand DNA breaks in Barrett's esophagus carcinogenesis via distinct mechanisms Gastroenterology 133 2007 1198 1209 (Pubitemid 47494447)
174. H.B. El Serag, T.V. Aguirre, and S. Davis Proton pump inhibitors are associated with reduced incidence of dysplasia in Barrett's esophagus Am J Gastroenterol 99 2004 1877 1883 (Pubitemid 39421227)
175. L.C. Hillman, L. Chiragakis, and B. Shadbolt Proton-pump inhibitor therapy and the development of dysplasia in patients with Barrett's oesophagus Med J Aust 180 2004 387 391 (Pubitemid 38528957)
176. B.T. Cooper, W. Chapman, and C.S. Neumann Continuous treatment of Barrett's oesophagus patients with proton pump inhibitors up to 13 years: observations on regression and cancer incidence Aliment Pharmacol Ther 23 2006 727 733 (Pubitemid 43344591)
177. D.M. Nguyen, H.B. El Serag, and L. Henderson Medication usage and the risk of neoplasia in patients with Barrett's esophagus Clin Gastroenterol Hepatol 7 2009 1299 1304
178. R. Ouatu-Lascar, R.C. Fitzgerald, and G. Triadafilopoulos Differentiation and proliferation in Barrett's esophagus and the effects of acid suppression Gastroenterology 117 1999 327 335 (Pubitemid 29352940)
179. F.T. Peters, S. Ganesh, and E.J. Kuipers Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus Scand J Gastroenterol 35 2000 1238 1244 (Pubitemid 32051635)
180. M. Umansky, W. Yasui, and A. Hallak Proton pump inhibitors reduce cell cycle abnormalities in Barrett's esophagus Oncogene 20 2001 7987 7991 (Pubitemid 34001559)
181. L.A. Garca Rodrguez, J. Lagergren, and M. Lindblad Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK Gut 55 2006 1538 1544 (Pubitemid 44629198)
182. W.H. Chow, W.D. Findkle, and J.K. McLaughlin The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia JAMA 274 1995 474 477
183. D.C. Garrow, T.L. Vaughan, and C. Sweeney Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer Cancer Causes Control 11 2000 231 238 (Pubitemid 30182140)
184. M.A. Molina, M. Sitja-Arnau, and M.G. Lemoine Increased cyclooxygenase-2 expression in human pancreatic carcinomas and cell lines: growth inhibition by nonsteroidal anti-inflammatory drugs Cancer Res 59 1999 4356 4362 (Pubitemid 29418754)
185. G.A. Piazza, A.L. Rahm, and M. Krutzsch Antineoplastic drugs sulindac sulfide and sulfone inhibit cell growth by inducing apoptosis Cancer Res 55 1995 3110 3116
186. R.F. Souza, K. Shewmake, and D.G. Beer Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells Cancer Research 60 2000 5767 5772
187. N.S. Buttar, K.K. Wang, and M.A. Anderson The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study J Natl Cancer Inst 94 2002 422 429 (Pubitemid 34285091)
188. S. Aggarwal, N. Taneja, and L. Lin Indomethacin-induced apoptosis in esophageal adenocarcinoma cells involves upregulation of Bax and translocation of mitochondrial cytochrome C independent of COX-2 expression Neoplasia 2 2000 346 356
189. B.H. von Rahden, H.J. Stein, and F. Puhringer Coexpression of cyclooxygenases (COX-1, COX-2) and vascular endothelial growth factors (VEGF-A, VEGF-C) in esophageal adenocarcinoma Cancer Res 65 2005 5038 5044 (Pubitemid 40827311)
190. N.S. Buttar, K.K. Wang, and O. Leontovich Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus Gastroenterology 122 2002 1101 1112 (Pubitemid 34267291)
191. K. Oyama, T. Fujimura, and I. Ninomiya A COX-2 inhibitor prevents the esophageal inflammation-metaplasia-adenocarcinoma sequence in rats Carcinogenesis 26 2005 565 570 (Pubitemid 41214145)
192. S.W. Kim, T.J. Jang, and K.H. Jung Sulindac prevents esophageal adenocarcinomas induced by gastroduodenal reflux in rats Yonsei Med J 48 2007 1020 1027
193. B.S. Kaur, N. Khamnehei, and M. Iravani Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus Gastroenterology 123 2002 60 67 (Pubitemid 34747526)
194. D.A. Corley, K. Kerlikowske, and R. Verma Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis Gastroenterology 124 2003 47 56 (Pubitemid 36055338)
195. C.C. Abnet, N.D. Freedman, and F. Kamangar Non-steroidal anti-inflammatory drugs and risk of gastric and oesophageal adenocarcinomas: results from a cohort study and a meta-analysis Br J Cancer 100 2009 551 557
196. T.L. Vaughan, L.M. Dong, and P.L. Blount Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: a prospective study Lancet Oncol 6 2005 945 952 (Pubitemid 41685227)
197. E.I. Heath, M.I. Canto, and S. Piantadosi Secondary chemoprevention of Barrett's esophagus with celecoxib: results of a randomized trial J Natl Cancer Inst 99 2007 545 557 (Pubitemid 47073557)
198. K.R. McQuaid, and L. Laine Systematic review and meta-analysis of adverse events of low-dose aspirin and clopidogrel in randomized controlled trials Am J Med 119 2006 624 638 (Pubitemid 44128438)
199. F.K. Chan, S.C. Chung, and B.Y. Suen Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen N Engl J Med 344 2001 967 973 (Pubitemid 32240315)
200. K.C. Lai, S.K. Lam, and K.M. Chu Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use N Engl J Med 346 2003 2033 2038
201. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
202. M. Hayden, M. Pignone, and C. Phillips Aspirin for the primary prevention of cardiovascular events: a summary of the evidence for the U.S. Preventive Services Task Force Ann Intern Med 136 2002 161 172 (Pubitemid 34073943)
203. D. Das, A.P. Chilton, and J.A. Jankowski Chemoprevention of oesophageal cancer and the AspECT trial Recent Results Cancer Res 181 2009 161 169
204. D.A. Katzka, and D.O. Castell Successful elimination of reflux symptoms does not ensure adequate control of acid reflux in patients with Barrett's esophagus Am J Gastroenterol 89 1994 989 991 (Pubitemid 24201832)
205. R.W. Yeh, L.B. Gerson, and G. Triadafilopoulos Efficacy of esomeprazole in controlling reflux symptoms, intraesophageal, and intragastric pH in patients with Barrett's esophagus Dis Esophagus 16 2003 193 198 (Pubitemid 37427875)
206. L.B. Gerson, V. Boparai, and N. Ullah Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors Aliment Pharmacol Ther 20 2004 637 643 (Pubitemid 39279052)
207. S.R. DeMeester, and T.R. DeMeester Columnar mucosa and intestinal metaplasia of the esophagus Fifty years of controversy Ann Surg 231 2000 303 321
208. R.W. McCallum, S. Polepalle, and K. Davenport Role of anti-reflux surgery against dysplasia in Barrett's esophagus (abstr) Gastroenterology 100 1991 A121
209. D. Katz, R. Rothstein, and A. Schned The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus Am J Gastroenterol 93 1998 536 541 (Pubitemid 29080999)
210. S. Oberg, J. Wenner, and J. Johansson Barrett esophagus: risk factors for progression to dysplasia and adenocarcinoma Ann Surg 242 2005 49 54 (Pubitemid 40917967)
211. S.J. Spechler, E. Lee, and D. Ahnen Long-term outcome of medical and surgical treatments for gastroesophageal reflux disease Follow-up of a randomized controlled trial JAMA 285 2001 2331 2338 (Pubitemid 32424101)
212. W. Ye, W.H. Chow, and J. Lagergren Risk of adenocarcinoma of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery Gastroenterology 121 2001 1286 1293 (Pubitemid 33140445)
213. T. Tran, S.J. Spechler, and H.B. El-Serag Fundoplication and the risk of cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study Am J Gastroenterol 100 2005 1002 1008 (Pubitemid 40769033)
214. K.E. Corey, S.M. Schmitz, and N.J. Shaheen Does a surgical antireflux procedure decrease the incidence of esophageal adenocarcinoma in Barrett's esophagus? A meta-analysis Am J Gastroenterol 98 2003 2390 2394 (Pubitemid 37448746)
215. Y.M. Li, L. Li, and C.H. Yu A systematic review and meta-analysis of the treatment for Barrett's esophagus Dig Dis Sci 53 2008 2837 2846
216. T.W. Rice, G. Zuccaro, and D.J. Adelstein Esophageal carcinoma: depth of tumor invasion is predictive of regional lymph node status Ann Thorac Surg 65 1998 787 792 (Pubitemid 28162480)
217. M. Feith, H.J. Stein, and J.R. Siewert Pattern of lymphatic spread of Barrett's cancer World J Surg 27 2003 1052 1057 (Pubitemid 37186242)
218. D.S. Oh, J.A. Hagen, and P.T. Chandrasoma Clinical biology and surgical therapy of intramucosal adenocarcinoma of the esophagus J Am Coll Surg 203 2006 152 161 (Pubitemid 44080639)
219. C.G. Peyre, S.R. DeMeester, and C. Rizzetto Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia Ann Surg 246 2007 665 671 (Pubitemid 47480620)
220. H.J. Stein, M. Feith, and B.L. Bruecher Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection Ann Surg 242 2005 566 573
221. G.W. Falk, M.F. Catalano, and M.V. Sivak Jr Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia Gastrointest Endosc 40 1994 207 212 (Pubitemid 24129200)
222. I. Waxman, G.S. Raju, and J. Critchlow High frequency probe ultrasonography has limited accuracy for detecting invasive adenocarcinoma in patients with Barrett's esophagus and high grade dysplasia or intramucosal carcinoma: a case series Am J Gastroenterol 101 2006 1773 1779 (Pubitemid 44166585)
223. A. Larghi, C.J. Lightdale, and L. Memeo EUS followed by EMR for staging of high-grade dysplasia and early cancer in Barrett's esophagus Gastrointest Endosc 62 2005 16 23 (Pubitemid 40922435)
224. G.A. Prasad, N.S. Buttar, and L.M. Wongkeesong Significance of neoplastic involvement of margins obtained by endoscopic mucosal resection in Barrett's esophagus Am J Gastroenterol 102 2007 2380 2386 (Pubitemid 47631763)
225. M. Giovannini, E. Bories, and C. Pesenti Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer Preliminary results in 21 patients Endoscopy 36 2004 782 787 (Pubitemid 39207151)
226. S. Seewald, T. Akaraviputh, and U. Seitz Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma Gastrointest Endosc 57 2003 854 859 (Pubitemid 47241100)
227. F.P. Peters, M.A. Kara, and W.D. Rosmolen Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study Am J Gastroenterol 101 2006 1449 1457 (Pubitemid 43980615)
228. M. Conio, A. Repici, and R. Cestari Endoscopic mucosal resection for high-grade dysplasia and intramucosal carcinoma in Barrett's esophagus: an Italian experience World J Gastroenterol 11 2005 6650 6655 (Pubitemid 43072705)
229. N. Soehendra, S. Seewald, and S. Groth Use of modified multiband ligator facilitates circumferential EMR in Barrett's esophagus (with video) Gastrointest Endosc 63 2006 847 852
230. A. Larghi, C.J. Lightdale, and A.S. Ross Long-term follow-up of complete Barrett's eradication endoscopic mucosal resection (CBE-EMR) for the treatment of high grade dysplasia and intramucosal carcinoma Endoscopy 39 2007 1086 1091
231. C.V. Lopes, M. Hela, and C. Pesenti Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma Surg Endosc 21 2007 820 824 (Pubitemid 46675513)
232. O. Pech, A. Behrens, and A. May Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus Gut 57 2008 1200 1206
233. C.G. Montes, N.A. Brandalise, and R. Deliza Antireflux surgery followed by bipolar electrocoagulation in the treatment of Barrett's esophagus Gastrointest Endosc 50 1999 173 177 (Pubitemid 29380361)
234. R.E. Sampliner, D. Faigel, and M.B. Fennerty Effective and safe endoscopic reversal of nondysplastic Barrett's esophagus with thermal electrocoagulation combined with high-dose acid inhibition: a multicenter study Gastrointest Endosc 53 2001 554 558 (Pubitemid 33587026)
235. P. Sharma, S. Wani, and A.P. Weston A randomised controlled trial of ablation of Barrett's oesophagus with multipolar electrocoagulation versus argon plasma coagulation in combination with acid suppression: long term results Gut 55 2006 1233 1239 (Pubitemid 44277352)
236. G.S. Dulai, D.M. Jensen, and G. Cortina Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus Gastrointest Endosc 61 2005 232 240 (Pubitemid 40261071)
237. A. Madisch, S. Miehlke, and E. Bayerdorffer Long-term follow-up after complete ablation of Barrett's esophagus with argon plasma coagulation World J Gastroenterol 11 2005 1182 1186 (Pubitemid 40353006)
238. H. Mork, O. Al-Taie, and F. Berlin High recurrence rate of Barrett's epithelium during long-term follow-up after argon plasma coagulation Scand J Gastroenterol 42 2007 23 27 (Pubitemid 46033042)
239. C.J. Kelty, R. Ackroyd, and N.J. Brown Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation Aliment Pharmacol Ther 20 2004 1289 1296 (Pubitemid 40040075)
240. T. Bright, D.I. Watson, and W. Tam Prospective randomized trial of argon plasma coagulation ablation versus endoscopic surveillance of Barrett's esophagus in patients treated with antisecretory medication Dig Dis Sci 2008 Dec 20 [Epub ahead of print]
241. V.K. Sharma, K.K. Wang, and B.F. Overholt Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients Gastrointest Endosc 65 2007 185 195 (Pubitemid 46157125)
242. D.E. Fleischer, B.F. Overholt, and V.K. Sharma Endoscopic ablation of Barrett's esophagus: a multicenter study with 2.5-year follow-up Gastrointest Endosc 68 2008 867 876
243. H. Manner, A. May, and S. Miehlke Ablation of nonneoplastic Barrett's mucosa using argon plasma coagulation with concomitant esomeprazole therapy (APBANEX): a prospective multicenter evaluation Am J Gastroenterol 101 2006 1762 1769 (Pubitemid 44166583)
244. J.M. Inadomi, M. Somsouk, and R.D. Madanick A cost-utility analysis of ablative therapy for Barrett's esophagus Gastroenterology 136 2009 2101 2114
245. L. Familiari, M. Scaffidi, and M. Bonica Endoscopic treatment of Barrett's epithelium with argon plasma coagulation Long-term follow-up Minerva Gastroenterol Dietol 49 2003 63 70 (Pubitemid 36505761)
246. R. Ackroyd, C.J. Kelty, and N.J. Brown Eradication of dysplastic Barrett's oesophagus using photodynamic therapy: long-term follow-up Endoscopy 35 2003 496 501 (Pubitemid 36705640)
247. B.F. Overholt, M. Panjehpour, and D.L. Halberg Photodynamic therapy for Barrett's esophagus with dysplasia and/or early stage carcinoma: long-term results Gastrointest Endosc 58 2003 183 188 (Pubitemid 38220265)
248. K. Ragunath, N. Krasner, and V.S. Raman Endoscopic ablation of dysplastic Barrett's oesophagus comparing argon plasma coagulation and photodynamic therapy: a randomized prospective trial assessing efficacy and cost-effectiveness Scand J Gastroenterol 40 2005 750 758 (Pubitemid 40978849)
249. V.K. Sharma, J.H. Kim, and A. Das Circumferential and focal ablation of Barrett's esophagus containing dysplasia Am J Gastroenterol 104 2009 310 317
250. N.J. Shaheen, P. Sharma, and B.F. Overholt Radiofrequency ablation in Barrett's esophagus with dysplasia N Engl J Med 360 2009 2277 2288
251. F.P. Peters, M.A. Kara, and W.D. Rosmolen Stepwise radical endoscopic resection is effective for complete removal of Barrett's esophagus with early neoplasia: a prospective study Am J Gastroenterol 101 2006 1449 1457 (Pubitemid 43980615)
252. B.F. Overholt, C.J. Lightdale, and K.K. Wang Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial Gastrointest Endosc 62 2005 488 498 (Pubitemid 41383764)
253. B.F. Overholt, K.K. Wang, and J.S. Burdick Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia Gastrointest Endosc 66 2007 460 468 (Pubitemid 47304412)
254. L. Gossner, M. Stolte, and R. Sroka Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid Gastroenterology 114 1998 448 455
255. O. Pech, L. Gossner, and A. May Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia Gastrointest Endosc 62 2005 24 30 (Pubitemid 40922436)
256. R.A. Ganz, B.F. Overholt, and V.K. Sharma Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia a U.S. multicenter registry Gastrointest Endosc 68 2008 35 40 (Pubitemid 351902211)
257. M. Johnston, J.A. Eastone, and J.D. Horwat Cryoablation of Barrett's esophagus: a pilot study Gastrointest Endosc 62 2005 842 848 (Pubitemid 41654416)
258. J.A. Dumot, J.J. Vargo II, and G.W. Falk An open-label, prospective trial of cryospray ablation for Barrett's esophagus high-grade dysplasia and early esophageal cancer in high-risk patients Gastrointest Endosc 70 2009 635 644
259. S.E. Attwood, C.J. Lewis, and S. Caplin Argon beam plasma coagulation as therapy for high-grade dysplasia in Barrett's esophagus Clin Gastroenterol Hepatol 1 2003 258 263 (Pubitemid 37254452)
260. R.E. Pouw, K. Wirths, and P. Eisendrath Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia Clin Gastroenterol Hepatol 8 2010 23 29
261. S. Wani, H. Sayana, and P. Sharma Endoscopic eradication of Barrett's esophagus Gastrointest Endosc 71 2010 147 166
262. M.P. Bronner, B.F. Overholt, S.L. Taylor International Photodynamic Therapy Group for High-Grade Dysplasia in Barrett's Esophagus Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia Gastroenterology 136 2009 56 64
263. S. Wani, S.R. Puli, and N.J. Shaheen Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review Am J Gastroenterol 104 2009 502 513
264. R.A. Meguid, E.S. Weiss, and D.C. Chang The effect of volume on esophageal cancer resections: what constitutes acceptable resection volumes for centers of excellence? J Thorac Cardiovasc Surg 137 2009 23 29
265. J.J.B. Van Lanschot, J.B.F. Hulscher, and C.J. Buskens Hospital volume and hospital mortality for esophagectomy Cancer 91 2001 1574 1578 (Pubitemid 32319271)
266. J.B. Dimick, P.J. Pronovost, and J.A. Cowan Surgical volume and quality of care for esophageal resection: do high-volume hospitals have fewer complications? Ann Thorac Surg 75 2003 337 341 (Pubitemid 36184466)
267. J.B. Dimick, S.M. Cattaneo, and P.A. Lipsett Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland Ann Thorac Surg 72 2001 334 341
268. C.B. Begg, L.D. Cramer, and W.J. Hoskins Impact of hospital volume on operative mortality for major cancer surgery JAMA 280 1998 1747 1751 (Pubitemid 28536874)
269. M.G. Patti, C.U. Corvera, and R.E. Glasgow A hospital's annual rate of esophagectomy influences the operative mortality rate J Gastrointest Surg 2 1998 186 192 (Pubitemid 128432031)
270. J.D. Birkmeyer, A.E. Siewers, and E.V.A. Finlayson Hospital volume and surgical mortality in the United States N Engl J Med 346 2002 1128 1137 (Pubitemid 34984604)
271. G.A. Prasad, T.T. Wu, and D.A. Wigle Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus Gastroenterology 137 2009 815 823
272. V.S. Wang, J.L. Hornick, and J.A. Sepulveda Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience Gastrointest Endosc 69 2009 777 783
273. N.K. Altorki, P.C. Lee, and Y. Liss Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment Ann Surg 247 2008 434 439
274. D.B. Schembre, J.L. Huang, and O.S. Lin Treatment of Barrett's esophagus with early neoplasia: a comparison of endoscopic therapy and esophagectomy Gastrointest Endosc 67 2008 595 601
275. V. Muntiz, L.F. Martnez de Haro, and M.A. Ortiz [Surgical treatment of high-grade dysplasia in Barrett's esophagus ] Cir Esp 82 2007 214 218
276. V.A. Williams, T.J. Watson, and F.A. Herbella Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome J Gastrointest Surg 11 2007 1589 1597
277. C.G. Peyre, S.R. DeMeester, and C. Rizzetto Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia Ann Surg 246 2007 665 671 (Pubitemid 47480620)
278. R.J. Moraca, and D.E. Low Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer Arch Surg 141 2006 545 549
279. L.C. Chang, B.K. Oelschlager, and E. Quiroga Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus J Gastrointest Surg 10 2006 341 346 (Pubitemid 43303827)
280. V. Sujendran, G. Sica, and B. Warren Oesophagectomy remains the gold standard for treatment of high-grade dysplasia in Barrett's oesophagus Eur J Cardiothorac Surg 28 2005 763 766 (Pubitemid 41539334)
281. M.F. Reed, G. Tolis Jr, and B.H. Edil Surgical treatment of esophageal high-grade dysplasia Ann Thorac Surg 79 2005 1110 1115 (Pubitemid 40431823)
282. R.J. Pacifico, K.K. Wang, and L.M. Wongkeesong Combined endoscopic mucosal resection and photodynamic therapy versus esophagectomy for management of early adenocarcinoma in Barrett's esophagus Clin Gastroenterol Hepatol 1 2003 252 257 (Pubitemid 37254451)
283. R.F. Heitmiller Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia Langenbecks Arch Surg 388 2003 83 87 (Pubitemid 37092723)
284. B.N. Thomson, and R.J. Cade Oesophagectomy for early adenocarcinoma and dysplasia arising in Barrett's oesophagus ANZ J Surg 73 2003 121 124 (Pubitemid 36513095)
285. E.E. Tseng, T.T. Wu, and C.J. Yeo Barrett's esophagus with high grade dysplasia: surgical results and long-term outcomean update J Gastrointest Surg 7 2003 164 170
286. Y. Perry, H.C. Fernando, and P.O. Buenaventura Minimally invasive esophagectomy in the elderly JSLS 6 2002 299 304
287. J. Scott Bolton, T.T. Wu, and C.J. Yeo Esophagectomy for adenocarcinoma in patients 45 years of age and younger J Gastrointest Surg 5 2001 620 625 (Pubitemid 33651268)
288. J.R. Headrick, F.C. Nichols III, and D.L. Miller High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy Ann Thorac Surg 73 2002 1697 1702
289. G. Zaninotto, A.R. Parenti, and A. Ruol Oesophageal resection for high-grade dysplasia in Barrett's oesophagus Br J Surg 87 2000 1102 1105 (Pubitemid 30496863)
290. N.T. Nguyen, P. Schauer, and J.D. Luketich Minimally invasive esophagectomy for Barrett's esophagus with high-grade dysplasia Surgery 127 2000 284 290 (Pubitemid 30140625)
291. G. Catrambone, G. Leoncini, and L. Iurilli Complications of Barrett's esophagus: indications for esophageal resection with special reference to high-grade dysplasia Minerva Chir 54 1999 657 667 (Pubitemid 29509382)
292. M.G. Patti, M. Arcerito, and C.V. Feo Barrett's esophagus: a surgical disease J Gastrointest Surg 3 1999 397 403
293. J.D. Luketich, N.T. Nguyen, and T. Weigel Minimally invasive approach to esophagectomy JSLS 2 1998 243 247
294. A.H. Hlscher, E. Bollschweiler, and P.M. Schneider Early adenocarcinoma in Barrett's oesophagus Br J Surg 84 1997 1470 1473 (Pubitemid 27443460)
295. R.F. Heitmiller, M. Redmond, and S.R. Hamilton Barrett's esophagus with high-grade dysplasia An indication for prophylactic esophagectomy Ann Surg 224 1996 66 71 (Pubitemid 26227409)
296. M.J. Edwards, D.R. Gable, and A.B. Lentsch The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia Ann Surg 223 1996 585 589
297. V.W. Rusch, D.S. Levine, and R. Haggitt The management of high grade dysplasia and early cancer in Barrett's esophagus A multidisciplinary problem Cancer 74 1994 1225 1229 (Pubitemid 24301772)
298. T. Lerut, W. Coosemans, and D. Van Raemdonck Surgical treatment of Barrett's carcinoma Correlations between morphologic findings and prognosis J Thorac Cardiovasc Surg 107 1994 1059 1065
299. T.W. Rice, G.W. Falk, and E. Achkar Surgical management of high-grade dysplasia in Barrett's esophagus Am J Gastroenterol 88 1993 1832 1836 (Pubitemid
300. M. Pera, V.F. Trastek, and H.A. Carpenter Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 54 1992 199 204
301. R. Parameswaran, A. McNair, and K.N. Avery The role of health-related quality of life outcomes in clinical decision making in surgery for esophageal cancer: a systematic review Ann Surg Oncol 15 2008 2372 2379
302. N. Safieddine, W. Xu, and S.M. Quadri Health-related quality of life in esophageal cancer: effect of neoadjuvant hemoradiotherapy followed by surgical intervention J Thorac Cardiovasc Surg 137 2009 36 42
303. E. van Meerten, A. van der Gaast, and C.W. Looman Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma Int J Radiat Oncol Biol Phys 71 2008 160 166
304. A.G. de Boer, J.J. van Lanschot, and J.W. van Sandick Quality of life after transhiatal compared with extended transthoracic resection for adenocarcinoma of the esophagus J Clin Oncol 22 2004 4202 4208 (Pubitemid 41185191)
305. J.M. Blazeby, J.R. Farndon, and J. Donovan A prospective longitudinal study examining the quality of life of patients with esophageal carcinoma Cancer 88 2000 1781 1787 (Pubitemid 30212985)
306. T. Djrv, J. Lagergren, and J.M. Blazeby Long-term health-related quality of life following surgery for oesophageal cancer Br J Surg 95 2008 1121 1126
307. K.N. Avery, C. Metcalfe, and C.P. Barham Quality of life during potentially curative treatment for locally advanced oesophageal cancer Br J Surg 94 2007 1369 1376 (Pubitemid 350144385)
308. A.J. McLarty, C. Deschamps, and V.F. Trastek Esophageal resection for cancer of the esophagus: long-term function and quality of life Ann Thorac Surg 63 1997 1568 1572 (Pubitemid 27321515)
309. P. Lagergren, K.N. Avery, and R. Hughes Health-related quality of life among patients cured by surgery for esophageal cancer Cancer 110 2007 686 693 (Pubitemid 47106160)
310. A.G. De Boer, P.I. Genovesi, and M.A. Sprangers Quality of life in long-term survivors after curative transhiatal oesophagectomy for esophageal carcinoma Br J Surg 87 2000 1716 1721
311. S. Oberg, J. Johansson, and J. Wenner Metaplastic columnar mucosa in the cervical esophagus after esophagectomy Ann Surg 235 2002 338 345 (Pubitemid 34183884)
312. S.M. Dresner, S.M. Griffin, and J. Wayman Human model of duodenogastro-oesophageal reflux in the development of Barrett's metaplasia Br J Surg 90 2003 1120 1128 (Pubitemid 37152171)
313. D. Franchimont, A. Covas, and C. Brasseur Newly developed Barrett's esophagus after subtotal esophagectomy Endoscopy 35 2003 850 853 (Pubitemid 37254220)
314. J.M. O'Riordan, O.N. Tucker, and P.J. Byrne Factors influencing the development of Barrett's epithelium in the esophageal remnant postesophagectomy Am J Gastroenterol 99 2004 205 211 (Pubitemid 38279858)
315. R.V. Lord, K. Wickramasinghe, and J.J. Johansson Cardiac mucosa in the remnant esophagus after esophagectomy is an acquired epithelium with Barrett's-like features Surgery 136 2004 633 640 (Pubitemid 39186577)
316. J.R. da Rocha, U. Ribeiro Jr, and R.A. Sallum Barrett's esophagus (BE) and carcinoma in the esophageal stump (ES) after esophagectomy with gastric pull-up in achalasia patients: a study based on 10 years follow-up Ann Surg Oncol 15 2008 2903 2909
317. C.A. Gutschow, D. Vallbhmer, and M. Stolte Adenocarcinoma developing in de novo Barrett's mucosa in the remnant esophagus after esophagectomy: clinical and molecular assessment Dis Esophagus 21 2008 E6 E8
318. H.C. Wolfsen, L.L. Hemminger, and K.R. DeVault Recurrent Barrett's esophagus and adenocarcinoma after esophagectomy BMC Gastroenterol 4 2004 18